Home > PS Ratio > INDSWIFT LABORATORIES

INDSWIFT LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of INDSWIFT LABORATORIES is 0.49.

Share Price ₹105.7May 27,2024
Market Cap ₹624.7 Cr
Sales-TTM₹1,280.9 CrTTM-Consolidated Results
Price/Sales0.49xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for INDSWIFT LABORATORIES
Please provide your vote to see the results
INDSWIFT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of INDSWIFT LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of INDSWIFT LABORATORIES is calculated as :

Current Market Cap [ ₹624.7 Cr] as on May 27,2024

(/) Sales [ ₹1,280.9 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 0.49x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for INDSWIFT LABORATORIES , the investors are currently willing to pay '0.49 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of INDSWIFT LABORATORIES !

The chart below summarizes the trend in P/S Ratio of INDSWIFT LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of INDSWIFT LABORATORIES


PS Ratio Performance Analysis for INDSWIFT LABORATORIES

- INDSWIFT LABORATORIES 's latest p/e ratio is 0.49x.

- INDSWIFT LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.31x.

- INDSWIFT LABORATORIES 's operated at median p/e ratio of 0.27x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INDSWIFT LABORATORIES 's p/e ratio peaked in Mar2021 at 0.48x.

- INDSWIFT LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.16x.


How does INDSWIFT LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
INDSWIFT LABORATORIES 1,280.90.49624.7
SUN PHARMACEUTICAL INDUSTRIES LTD48,496.97.26351,910.0
CIPLA LTD25,774.14.63119,369.0
DR REDDYS LABORATORIES LTD28,011.13.5098,161.7
ZYDUS LIFESCIENCES LTD19,547.45.45106,515.0
DIVIS LABORATORIES LTD7,845.014.40112,930.0
MANKIND PHARMA LTD10,334.88.2084,734.3
TORRENT PHARMACEUTICALS LTD10,728.08.3789,825.1
LUPIN LTD20,010.83.6873,653.0
AUROBINDO PHARMA LTD29,001.92.4270,057.8
ABBOTT INDIA LTD5,848.99.5355,769.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INDSWIFT LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.49x
Max industry PS 14.40x
Median industry PS 5.45x
Average industry PS 6.18x



You may also like the below Video Courses